91.5 Chapel Hill 88.9 Manteo 90.9 Rocky Mount 91.1 Welcome 91.9 Fayetteville 90.5 Buxton 94.1 Lumberton 99.9 Southern Pines 89.9 Chadbourn

FDA Expected To Approve Esketamine Nasal Spray For Depression

By Jon Hamilton
Published March 4, 2019 at 7:41 PM EST
  • Facebook
  • Twitter
  • LinkedIn
  • Email

Your browser doesn’t support HTML5 audio

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

All Things Considered
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
See stories by Jon Hamilton
More Stories
  1. WHO Points To Wildlife Farms In Southern China As Likely Source Of Pandemic
  2. Biden Has Options To Leverage Trump's Sanctions On Iran
  3. 'Why Are We Playing College Basketball Right Now?': NCAA And COVID-19
  4. One Of The Heaviest Snowstorms On Record Hits Rocky Mountains
  5. The Podcast 'Spectacle' Covers Reality TV, 1 Franchise At A Time